Loading provider…
Loading provider…
Hematology & Oncology Physician in Plantation, FL
NPI: 1679561294Primary Practice Location
WESTSIDE REGIONAL MEDICAL CENTER
8201 W Broward Blvd, Plantation, FL
Primary Employer
New Century Health
newcenturyhealth.com
HQ Phone
Get D.O. Jason's Phone Numberphone_androidMobile
Get D.O. Jason's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License

FL State License
2002 - 2026

NY State License
2004 - 2011

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Dr. Kiran C. Patel College of Osteopathic Medicine
osteopathic.nova.edu
Medical School
Until 1999
Maimonides Medical Center
Fellowship • Hematology and Medical Oncology
2003 - 2006
Residency • Internal Medicine
2000 - 2003
Palmetto General Hospital
Internship • Transitional Year
1999 - 2000
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 246 | 916 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 175 | 391 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 118 | 184 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 77 | 87 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 63 | 131 |
Authors: Alexandre Daniel Sintow, Tina Binazir, Sameer Shaharyar
Journal: Cureus
Publication Date: 2017-06-27
Authors: Fach, P, Dilasser, F, Grout, J, Tache, J
Journal: J Food Prot
Authors: Auvray, F, Lecureuil, C, Taché, J, Perelle, S, Fach, P
Journal: J Appl Microbiol
Publication Date: 2007-10-22
Lead Sponsor: Karyopharm Therapeutics Inc
Intervention / Treatment: DRUG: Dexamethasone, DRUG: Selinexor, DRUG: Bortezomib
Lead Sponsor: Syros Pharmaceuticals
Intervention / Treatment: DRUG: Venetoclax, DRUG: Azacitidine, DRUG: Tamibarotene
Lead Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)
Collaborators: Merck Sharp & Dohme LLC
Intervention / Treatment: DRUG: Pembrolizumab, DRUG: DPX-Survivac, DRUG: CPA